Adalvo Secures First EU Generic Approval for Liraglutide Pre-Filled Pen

SAN ĠWANN, Malta, June 13, 2024 (Korea Bizwire) – Adalvo announces the successful DCP approval for Liraglutide pre-filled pen, marking it as the first generic approval in the EU. As a bioequivalent version of Victoza® pre-filled pen, indicated for the treatment of type 2 diabetes, this peptide drug achieved global sales exceeding $4.8 billion in 2023, [...]